GianlucaIacobellisMD PhD

Diabetes, Lipid Metabolism, Obesity

Full Professor, Medicine, University of Miami Leonard M. Miller School of Medicine

Dr. Iacobellis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

My clinical activity focuses on the contemporary treatment and prevention of diabetes and diabetes related cardiovascular complications.
My research pioneered the role of epicardial fat as new cardiovascular risk factor and therapeutic target.

University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2005
University of Texas Southwestern Medical CenterPost-Doctoral Fellowship, 2004 - 2005
Sapienza University of RomeClass of 1994, MD, 110/110 cum laude

Office of Research, Research Education and Innovative Medicine University of Miami, 2017
Internal Career Award McMaster University, 2006
Whos Who in Medicine and Healthcare Marquis Whos Who

Liraglutide Hospital Discharge Trial Start of enrollment: 2014 Mar 01
Completed
Phase 4
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes Start of enrollment: 2014 Mar 01
Completed
Phase 4
Dapagliflozin Effects on Epicardial Fat Start of enrollment: 2015 Sep 01
Completed
Phase 4
Liraglutide Effects on Epicardial Fat Inflammatory Genes Start of enrollment: 2018 Sep 01
Recruiting
Phase 4
Healthsnap on Epicardial Adipose Tissue Study Start of enrollment: 2018 Jun 01
Completed
Not Applicable
Epicardial Fat in Coronary Artery Disease Start of enrollment: 2011 Dec 18
Completed
Semaglutide vs Dulaglutide on Epicardial Adipose Tissue Start of enrollment: 2019 Sep 24
Completed
Effects of DPP4 Inhibition on COVID-19 Start of enrollment: 2021 Jun 30
Withdrawn
Phase 4
Join now to see all

PubMed

Epicardial adipose tissue, cardiac damage, and mortality in patients undergoing TAVR for aortic stenosis.
Pamela Piña, Daniel Lorenzatti, Annalisa Filtz, Andrea Scotti, Elena Virosta Gil
The International Journal of Cardiovascular Imaging. 2025-01-18
How Semaglutide Effects on Epicardial Fat Inflammation Can Be Good for the Heart.
Gianluca Iacobellis, Alexis Elias Malavazos
Journal of the American College of Cardiology. 2025-01-07
Cardio-Lipotoxicity of Epicardial Adipose Tissue.
Monica L Bodenstab, Ron T Varghese, Gianluca Iacobellis
Biomolecules. 2024-11-18

Liraglutide effects on epicardial fat inflammatory genes in diabetes and coronary artery diseaseNovo Nordisk2018–Present
Effects of Dapagliflozin on Epicardial Fat in Subjects With Type 2 DiabetesAstra Zeneca2015–Present
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesNovo Nordisk2014–Present
Trans-omic analysis of epicardial adipose tissue in atrial fibrillationNIH2019–2023
Liragultide effects on Atrial Fibrillation (LEAF)NIH2019–2022